Binding conformations, QSAR, and molecular design of Alkene-3- quinolinecarbonitriles as Src inhibitors

International Journal of Quantum Chemistry

Volumn 113, Issue 10, 2013, Pages 1467-1478

  Zeng, G H ^a   Fang, D Q ^b   Wu, W J ^a   Zhang, R ^a   Xie, W G ^a   Wu, J H ^c   Shen, Y ^c  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

alkene 3 quinolinecarbonitriles; docking study; Src inhibitor; three dimensional quantitative structure activity relationship

Indexed keywords

ALKENE-3-QUINOLINECARBONITRILES; BINDING CONFORMATIONS; COMPARATIVE MOLECULAR FIELD ANALYSIS; COMPARATIVE-MOLECULAR-SIMILARITY-INDICES ANALYSIS; DOCKING STUDIES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS; SRC INHIBITOR; THREE-DIMENSIONAL QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

COMPUTATIONAL CHEMISTRY; ENZYME INHIBITION; HYDROCARBONS; MOLECULAR GRAPHICS; THREE DIMENSIONAL COMPUTER GRAPHICS;

THREE DIMENSIONAL;

EID: 84875844492     PISSN: 00207608     EISSN: 1097461X     Source Type: Journal    
DOI: 10.1002/qua.24344     Document Type: Article

References (54)

1. S. A. Courtneidge, Biochem. Soc. Trans. 2002, 30, 11.
2. S. A. Courtneidge, Non-receptor protein tyrosine kinases;, J. Woodgett, Ed.; Oxford University Press. 1994; pp. 212-240.
3. R. B. Irby, T. J. Yeatman, Oncogene 2000, 19, 5636.
4. S. M. Thomas, J. S. Brogge, Annu. Rev. Cell Dev. Biol. 1997, 13, 513.
5. S. J. Corey, S. M. Anderson, Blood 1999, 93, 1.
6. R. S. Finn, Ann. Oncol. 2008, 19, 1379.
7. G. Giaccone, P. A. Zucali, Ann. Oncol. 2008, 19, 1219.
8. D. J. Maly, I. C. Choong, J. A. Ellman, Proc. Natl. Acad. Sci. 2000, 97, 2419.
9. T. J. Yeatman, Nat. Rev. 2004, 4, 470.
10. R. L. Dow, B. M. Bechle, T. T. Chou, C. Goddard, E. R. Larson, Bioorg. Med. Chem. Lett. 1995, 5, 1007.
11. J. H. Hanke, J. P. Gardner, R. L. Dow, P. S. Changelian, W. H. Brissette, E. J. Weringer, B. A. Pollok, P. A. Connelly, J. Biol. Chem. 1996, 271, 695.
12. M. R. Myers, N. N. Setzer, A. P. Spada, A. L. Zulli, A. Zilberstein, S. E. Johnson, L. E. Hook, M. V. Jacoski, Bioorg. Med. Chem. Lett. 1997, 7, 417.
13. Y. H. Wang, W. C. Shakespeare, W. S. Huang, R. J. Sundaramoorthi, Bioorg. Med. Chem. Lett. 2008, 18, 4907.
14. A. Fallah Tafti, R. Tiwari, A. N. Shirazi, T. Akbarzadeh, D. Mandal, A. Shafiee, K. Parang, A. Foroumadi, Med. Chem. 2011, 7, 466.
15. A. M. Thompson, G. W. Rewcastle, S. L. Boushelle, B. G. Hartl, A. J. Kraker, G. H. Lu, B. L. Batley, R. L. Panek, W. A. Denny, J. Med. Chem. 2000, 43, 3134.
16. F. Musumeci, S. Schenone, C. Brullo, M. Botta, Future Med. Chem. 2012, 4, 799.
17. T. Chen, J. A. George, C. C. Taylor, Anticancer Drugs 2006, 17, 123.
18. L. C. Kim, L. Song, E. B. Haura, Nat. Rev. Clin. Oncol. 2009, 6, 587.
19. D. H. Boschelli, Y. D. Wang, S. Johnson, B. Wu, F. Ye, A. C. Barrios Sosa, J. M. Golas, F. Boschelli, Bio. Med. Chem. 2004, 47, 1599.
20. D. R. Huron, M. E. Gorre, A. J. Kraker, C. L. Sawyers, N. Roson, M. M. Moasser, Clin. Cancer Res. 2003, 9, 1267.
21. C. Dulsat, N. Mealy, R. Castaner, Drugs Future 2009, 34, 106.
22. J. A. Mcintyre, J. Castaner, M. Bayes, Drugs Future 2006, 31, 291.
23. D. H. Boschelli, F. Boschelli, Drugs Future 2007, 32, 481.
24. J. M. Golas, K. Arndt, C. Etienne, J. Lucas, D. Nardin, J. Gibbons, P. Frost, F. Ye, D. H. Boschelli, F. Boschelli, Cancer Res. 2003, 63, 375.
25. A. C. Barrios Sosa, D. H. Boschelli, F. Ye, J. M. Golas, F. Boschelli, Bioorg. Med. Chem. Lett. 2004, 14, 2155.
26. A. C. Barrios Sosa, D. H. Boschelli, B. Wu, Y. Wang, J. M. Golas, Bioorg. Med. Chem. Lett. 2005, 15, 1743.
27. D. H. Boschelli, D. Wang, Y. Wang, B. Wu, E. E. Honores, A. C. Barrios Sosa, I. Chaudhary, J. Golas, J. Lucas, F. Boschelli, Bioorg. Med. Chem. Lett. 2010, 20, 2924.
28. R. Thaimattam, P. R. Daga, R. Banerjee, J. Iqbal, Bioorg. Med. Chem. 2005, 13, 4704.
29. C. Gueto, J. L. Ruiz, J. E. Torres, J. Mendez, R. V. Reyes, Bioorg. Med. Chem. 2008, 16, 2439.
30. M. Sun, Y. G. Zheng, H. T. Wei, J. Q. Chen, M. Ji, J. Enzyme Inhib. Med. Chem. 2009, 24, 1109.
31. M. Sun, Y. G. Zheng, H. T. Wei, J. Q. Chen, J. Cai, M. Ji, QSAR Comb. Sci. 2009, 28, 312.
32. C. Hansch, T. E. Klein, Acc. Chem. Res. 1986, 19, 392.
33. V. P. Zambre, P. R. Murumkar, R. Giridhar, M. R. Yadav, J. Mol. Graph Model 2010, 29, 229.
34. S. Y. Liao, L. Qian, J. C. Chen, H. L. Lu, K. C. Zheng, Int. J. Quantum Chem. 2008, 108, 1380.
35. S. Y. Liao, L. Qian, T. F. Miao, H. L. Lu, K. C. Zheng, Int. J. Quantum Chem. 2009, 109, 999.
36. D. Irwin, D. T. Kuntz, P. Moustakas, L. Therese, Dock 6.0; Department of Pharmaceutical Chemistry, University of California, San Francisco, 2007.
37. SYBYL 6.9 [CP]. Tripos Associates, Inc.: St Louis, MO, 2001.
38. Chem3D Software. CambridgeSoft Crop.: Cambridge Park, MA, 2010.
39. M. Marsili, J. Gasteiger, Croat. Chem. Acta. 1980, 53, 601.
40. J. Gasteiger, M. Marsili, Tetrahedron 1980, 36, 3219.
41. F. Maseras, K. Morokuma, Chem. Phys. Lett. 1992, 195, 500.
42. A. E. Clark, J. L. Sonnenberg, P. J. Hay, R. L. Martin, J. Chem. Phys. 2004, 121, 2563.
43. S. J. Cho, A. Tropsha, J. Med. Chem. 1995, 38, 1060.
44. R. D. Cramer III, D. E. Patterson, J. D. Bunce, J. Am. Chem. Soc. 1988, 110, 5959.
45. G. Klebe, U. Abraham, T. Mietzner, J. Med. Chem. 1994, 37, 4130.
46. P. Geladi, Y. L. Xie, A. Polissar, P. Hopke, J. Chemometrics 1998, 12, 337.
47. S. Wold, A. Ruhe, H. Wold, W. J. Dunn, SIAM J. Sci. Stat. Comput. 1984, 5, 735.
48. A. Ali, J. C. Seung, Bioorg. Med. Chem. 2006, 14, 1474.
49. A. B. Bhoomendra, V. G. Veerappa, K. G. Andanappa, Bioorg. Med. Chem. 2005, 13, 2773.
50. A. Basu, K. Jasu, V. Jayaprakash, N. Mishra, P. Ojha, S. Bhattacharya, Eur. J. Med. Chem. 2009, 44, 2400.
51. P. Lu, X. Wei, R. Zhang, Eur. J. Med. Chem. 2010, 45, 3413.
52. Y. L. Yan, Y. Li, S. W. Zhang, C. Z. Ai, J. Mol. Graph Model 2011, 29, 747.
53. P. P. Roy, K. Roy, QSAR Comb. Sci. 2008, 27, 302.
54. D. R. Roy, U. Sarkar, P. K. Chattaraj, A. Mitra, J. Padmanabhan, R. Parthasarathi, V. Subramanian, S. Van Damme, P. Bultinck, Mol. Divers 2006, 10, 119.